The Few and the Proud: The Biotech Startup Class of 2012

Cerephex

GeneWeave Biosciences

Atreca [Added: 2:50 pm, 11/26/12]

 

New York/New Jersey

Cibiem

Seldar Pharma

Telsar Pharma

 

United Kingdom

Ziarco

CompanDX

 

Los Angeles/Orange County, CA

ImaginAb

Valcare

Thesan Pharmaceuticals

 

Research Triangle, NC

Vascular Pharmaceuticals

Aerial Biopharma

 

Ann Arbor, MI

Atterocor

 

Philadelphia, PA

Novira Therapeutics

Aclaris Therapeutics [Added: 3:35 pm PT, 12/3/12]

Toronto, ON

Xagenic

 

Cincinnati, OH

Aerpio Therapeutics

 

Cleveland, OH

BioMotiv [Added: 7:47 am PT, 11/28/12]

Baltimore, MD

Cerecor

Author: Luke Timmerman

Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.